Brief: Avenira Says Additional Investment From Sichuan Hebang Biotechnology
27/02/2026 01:38
Feb 27 (Reuters) - Avenira Ltd AEV.AX: ADDITIONAL INVESTMENT FROM SICHUAN HEBANG BIOTECHNOLOGY INVESTMENT COMPRISES PLACEMENT OF A$8.8 MILLION AT ISSUE PRICE OF A$0.0075 PER NEW SHARE Further company coverage: AEV.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avenira
See all newsBrief: Avenira Formally Approved A$2.6M Exploration Budget To Advance Jundee South Gold Project
Brief: Avenira Executes A$5 Mln Unsecured Loan Facility With MLHK Vehicle 1
Brief: Avenira Says Additional Investment From Sichuan Hebang Biotechnology
Brief: Avenira Appoints John He As Executive Chairman And CEO
Australia's Avenira gains on regulatory approval for phosphate mine